RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS - Cash Flow Statement (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
| Net income | $ 22,663 | $ 15,822 | $ 48,382 | $ 32,357 | $ 68,813 | $ 41,047 | $ 38,044 | $ 61,155 | $ 100,237 | ||||
| Provision for credit losses | $ 17,925 | $ 8,282 | 19,942 | $ 22,362 | $ 21,816 | 22,282 | 28,224 | 44,098 | 46,149 | 66,460 | 120,332 | 82,560 | 76,764 |
| Proceeds from sales of loans and leases held for sale | 78,514 | 57,952 | 269,958 | ||||||||||
| Accrued interest receivable | (569) | (366) | 18 | (1,065) | (904) | (4,224) | 8,804 | (4,360) | (1,448) | ||||
| Credit enhancement asset | (980) | (946) | (2,813) | (1,707) | (5,244) | (2,098) | (1,415) | (2,376) | (18,792) | ||||
| Other assets | 3,078 | 1,815 | (9,820) | (16,197) | 12,117 | (64,413) | (16,783) | (24,038) | 1,213 | ||||
| Accrued expenses and other liabilities | (5,157) | (14,949) | (4,801) | 9,995 | (13,675) | 30,834 | 18,022 | 27,579 | (13,579) | ||||
| Net cash provided by operating activities | 43,072 | 25,506 | 74,514 | 77,995 | 121,022 | 97,462 | 176,546 | 153,358 | 285,819 | ||||
| Net decrease (increase) in loans | 147,539 | (59,421) | 227,718 | (93,694) | 305,543 | (36,374) | 346,883 | 72,877 | (1,216,352) | ||||
| Proceeds from loans held for sale previously classified as portfolio loans | 84,283 | 40,899 | 0 | ||||||||||
| Net cash provided by (used in) investing activities | 26,914 | (107,910) | 34,361 | (203,084) | 32,212 | (174,028) | $ 136,708 | (74,800) | (1,137,641) | ||||
| As Previously Reported | |||||||||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
| Net income | 13,885 | 21,772 | 20,635 | 43,347 | 39,111 | 54,749 | 75,460 | 99,025 | |||||
| Provision for credit losses | 5,000 | 16,800 | 14,000 | 5,168 | 5,879 | 3,135 | 30,800 | 9,014 | 35,800 | 14,182 | 21,132 | 20,126 | |
| Proceeds from sales of loans and leases held for sale | 98,851 | 269,958 | |||||||||||
| Accrued interest receivable | (997) | (221) | (822) | (687) | (2,165) | (3,970) | (4,621) | (807) | |||||
| Credit enhancement asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Other assets | 1,034 | 4,423 | (16,278) | (11,380) | 5,203 | (58,408) | (18,731) | 876 | |||||
| Accrued expenses and other liabilities | (5,100) | (14,949) | (4,676) | 9,995 | (13,501) | 30,874 | 27,661 | (13,579) | |||||
| Net cash provided by operating activities | 26,917 | 16,008 | 44,983 | 60,803 | 78,214 | 67,283 | 154,638 | 247,065 | |||||
| Net decrease (increase) in loans | 163,694 | (49,923) | 257,249 | (76,502) | 348,351 | (6,195) | 112,496 | (1,177,598) | |||||
| Proceeds from loans held for sale previously classified as portfolio loans | 0 | 0 | |||||||||||
| Net cash provided by (used in) investing activities | 43,069 | (98,412) | 63,892 | (185,892) | 75,020 | (143,849) | (76,080) | (1,098,887) | |||||
| Adjustment | |||||||||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||||
| Net income | 8,778 | (5,950) | 27,747 | (10,990) | 29,702 | (13,702) | (14,305) | 1,212 | |||||
| Provision for credit losses | $ 12,925 | $ (8,518) | 5,942 | $ 17,194 | $ 15,937 | 19,147 | (2,576) | 35,084 | 10,349 | 52,278 | 61,428 | 56,638 | |
| Proceeds from sales of loans and leases held for sale | (40,899) | 0 | |||||||||||
| Accrued interest receivable | 428 | (145) | 840 | (378) | 1,261 | (254) | 261 | (641) | |||||
| Credit enhancement asset | (980) | (946) | (2,813) | (1,707) | (5,244) | (2,098) | (2,376) | (18,792) | |||||
| Other assets | 2,044 | (2,608) | 6,458 | (4,817) | 6,914 | (6,005) | (5,307) | 337 | |||||
| Accrued expenses and other liabilities | (57) | 0 | (125) | 0 | (174) | (40) | (82) | 0 | |||||
| Net cash provided by operating activities | 16,155 | 9,498 | 29,531 | 17,192 | 42,808 | 30,179 | (1,280) | 38,754 | |||||
| Net decrease (increase) in loans | (16,155) | (9,498) | (29,531) | (17,192) | (42,808) | (30,179) | (39,619) | (38,754) | |||||
| Proceeds from loans held for sale previously classified as portfolio loans | 40,899 | 0 | |||||||||||
| Net cash provided by (used in) investing activities | $ (16,155) | $ (9,498) | $ (29,531) | $ (17,192) | $ (42,808) | $ (30,179) | $ 1,280 | $ (38,754) | |||||